Amicus Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,292	2,248	3,267	2,847	2,377	4,407
Market Cap Growth	41.85%	-31.18%	14.75%	19.78%	-46.07%	135.18%
Enterprise Value	3,424	2,404	3,404	2,927	2,290	4,357
Last Close Price	10.50	7.52	11.19	10.01	8.66	18.11
PS Ratio	7.39	5.33	10.42	10.42	10.53	23.06
PB Ratio	19.21	14.51	25.98	27.88	10.47	21.01
P/TBV Ratio	247.46	-	-	-	29.37	67.93
EV/Sales Ratio	7.80	5.70	10.86	10.71	10.15	22.80
EV/EBITDA Ratio	95.34	70.63	-	-	-	-
EV/EBIT Ratio	135.33	88.35	-	-	-	-
Debt / Equity Ratio	1.92	2.29	2.78	3.67	1.43	1.54
Debt / EBITDA Ratio	9.04	8.61	-	-	-	-
Net Debt / Equity Ratio	0.78	1.00	0.99	1.29	-0.14	-0.14
Net Debt / EBITDA Ratio	4.25	4.55	-2.42	-0.80	0.22	0.18
Net Debt / FCF Ratio	18.47	-5.17	-2.08	-0.93	0.21	0.18
Asset Turnover	0.72	0.68	0.53	0.40	0.34	0.30
Inventory Turnover	0.42	0.59	0.89	1.53	1.49	1.85
Quick Ratio	1.90	2.36	2.23	2.59	3.67	4.09
Current Ratio	2.99	3.39	2.88	3.05	4.09	4.47
Return on Equity (ROE)	-6.87%	-31.68%	-107.04%	-109.93%	-84.37%	-72.59%
Return on Assets (ROA)	2.61%	2.72%	-6.12%	-15.68%	-13.95%	-17.55%
Return on Capital Employed (ROCE)	5.20%	5.40%	-12.00%	-34.90%	-26.30%	-32.20%
Earnings Yield	-0.32%	-1.99%	-3.64%	-6.90%	-7.78%	-4.60%
FCF Yield	0.22%	-1.33%	-1.84%	-4.97%	-6.41%	-3.93%
Buyback Yield / Dilution	-1.52%	-3.12%	-2.11%	-6.50%	-4.85%	-7.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.